temoporfin has been researched along with Angiogenesis, Pathologic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, CC; Chiang, PF; Chiang, WL; Lin, HC; Luo, TY; Peng, CL; Shieh, MJ; Shih, YH | 1 |
| Ortner, MA | 1 |
| Buchholz, J; Kaser-Hotz, B; Laluhová, D; Ohlerth, S; Roos, M; Walt, H | 1 |
1 review(s) available for temoporfin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Photodynamic therapy for cholangiocarcinoma: overview and new developments.
Topics: Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Hematoporphyrins; Humans; Interleukin-6; Mesoporphyrins; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents; Stents | 2009 |
2 other study(ies) available for temoporfin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Colorectal Neoplasms; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Kaplan-Meier Estimate; Mesoporphyrins; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents; Receptors, Vascular Endothelial Growth Factor; Tumor Burden; Vascular Endothelial Growth Factor A | 2018 |
Changes in vascularity and blood volume as a result of photodynamic therapy can be assessed with power Doppler ultrasonography.
Topics: Animals; Blood Volume; Carcinoma, Squamous Cell; Cats; Female; Image Processing, Computer-Assisted; Male; Mesoporphyrins; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents; Skin; Skin Neoplasms; Ultrasonography, Doppler | 2006 |